Back to List View Graph View

Nrf-2-SLC7A11-GSH pathway

The Nrf-2-SLC7A11-GSH pathway is a redox-regulatory cascade in which the transcription factor Nrf2 drives expression of SLC7A11 (xCT), the light chain of the cystine/glutamate antiporter system xc−, which imports cystine in exchange for exporting glutamate and so supplies the cysteine that limits glutathione (GSH) synthesis.

Where the papers sit

13 papers from the last 6 months study Nrf-2-SLC7A11-GSH pathway directly · updated from PubMed 11 Nov 2026

Study type 0 clinical trials · 13 preclinical

Themes one subject

Those 13 are all about one subject.

  • Nrf2 Oxidative Stress Biology

    Nrf2-driven antioxidant defense is being manipulated in opposite directions: strengthened to protect injured heart, liver, brain and motor-neuron cells, or weakened to expose cancers to ferroptosis and apoptosis. SLC7A11, GSH depletion and oxidative stress recur as the main control points. Nanoreactors, exosome-like vesicles, hydrogels and plant-derived compounds are used to amplify or restrain redox injury. The work remains preclinical, with therapeutic selectivity and pathway context still open.

    13 papers

Papers

The 13 papers from the last 6 months that study Nrf-2-SLC7A11-GSH pathway directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Nrf2 Oxidative Stress Biology (13)
  1. Wedelactone-loaded exosomes for sepsis-induced liver injury: a novel therapeutic strategy. Drug delivery · 1 Jul 2026 PMID 42381381
  2. A "Three-in-One" AuNRs@ZIF-8/AuNPs Nanoplatform: Nanoenzyme-Mediated SERS-Colorimetric Bimodal Detection of Intracellular Glutathione and Photothermal Therapy. ACS applied materials & interfaces · 24 Jun 2026 PMID 42339585
  3. COF-mediated tumor microenvironment-responsive platform and prodrug activation for combined chemo-sonodynamic cancer therapy. Journal of materials chemistry. B · 22 Jun 2026 PMID 42329078
  4. Reversible Disorder-to-Order Transition of Coacervates for Tumor Microenvironment-Responsive Intracellular Drug Delivery. ACS nano · 18 Jun 2026 PMID 42312698
  5. Pharmacological Activation of NRF2 by Omaveloxolone Upregulates NRF2-Target Proteins in SMA Type I Human Fibroblasts. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 16 Jun 2026 PMID 42301137
  6. Exosomal MALAT1 expression associated with the cardioprotective effects of carvacrol in acute doxorubicin-induced cardiac injury: Potential involvement of Nrf2/Keap1-related signaling. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 8 Jun 2026 PMID 42259137
  7. A catalytic redox-cycling nanoreactor enables robust oxidative stress amplification for synergistic tumor apoptosis and ferroptosis. Acta biomaterialia · 30 May 2026 PMID 42217658
  8. RAD1 promotes oxaliplatin resistance in gastric cancer by reinforcing NRF2-driven antioxidant defense and DDR checkpoint signaling. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy · 30 May 2026 PMID 42217457
  9. DIA-based proteomic analysis reveals Scutellaria barbata D. Don Exosome-like nanovesicles promote ferroptosis in HCC through Nrf2/SLC7A11/GPX4 pathway. Functional & integrative genomics · 28 May 2026 PMID 42209785
  10. Thymol nanoparticles ameliorate oxaliplatin-induced cognitive impairment via modulation of Nrf2/HO-1, endoplasmic reticulum stress, and NLRP3 inflammasome signaling in rats. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 27 May 2026 PMID 42202464
  11. In situ forming hydrogel incorporating celastrol-loaded copper-doped Prussian blue nanoparticles for oxidative stress amplified multimodal breast cancer therapy. International journal of pharmaceutics · 24 May 2026 PMID 42177922
  12. Advanced glycation end-products exacerbate myocardial ischemia/reperfusion injury by promoting mitochondrial oxidative damage and PANoptosis in diabetes mellitus. Redox biology · 23 May 2026 PMID 42176503
  13. Paris polyphylla saponin Ⅱ induces autophagy-associated ferroptosis by regulating the BECLIN1/SLC7A11 axis in cervical cancer. European journal of pharmacology · 20 May 2026 PMID 42162690

By study type

Preclinical: animal, cell and lab studies (13)
  1. Wedelactone-loaded exosomes for sepsis-induced liver injury: a novel therapeutic strategy. Drug delivery · 1 Jul 2026 PMID 42381381
  2. A "Three-in-One" AuNRs@ZIF-8/AuNPs Nanoplatform: Nanoenzyme-Mediated SERS-Colorimetric Bimodal Detection of Intracellular Glutathione and Photothermal Therapy. ACS applied materials & interfaces · 24 Jun 2026 PMID 42339585
  3. COF-mediated tumor microenvironment-responsive platform and prodrug activation for combined chemo-sonodynamic cancer therapy. Journal of materials chemistry. B · 22 Jun 2026 PMID 42329078
  4. Reversible Disorder-to-Order Transition of Coacervates for Tumor Microenvironment-Responsive Intracellular Drug Delivery. ACS nano · 18 Jun 2026 PMID 42312698
  5. Pharmacological Activation of NRF2 by Omaveloxolone Upregulates NRF2-Target Proteins in SMA Type I Human Fibroblasts. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 16 Jun 2026 PMID 42301137
  6. Exosomal MALAT1 expression associated with the cardioprotective effects of carvacrol in acute doxorubicin-induced cardiac injury: Potential involvement of Nrf2/Keap1-related signaling. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 8 Jun 2026 PMID 42259137
  7. A catalytic redox-cycling nanoreactor enables robust oxidative stress amplification for synergistic tumor apoptosis and ferroptosis. Acta biomaterialia · 30 May 2026 PMID 42217658
  8. RAD1 promotes oxaliplatin resistance in gastric cancer by reinforcing NRF2-driven antioxidant defense and DDR checkpoint signaling. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy · 30 May 2026 PMID 42217457
  9. DIA-based proteomic analysis reveals Scutellaria barbata D. Don Exosome-like nanovesicles promote ferroptosis in HCC through Nrf2/SLC7A11/GPX4 pathway. Functional & integrative genomics · 28 May 2026 PMID 42209785
  10. Thymol nanoparticles ameliorate oxaliplatin-induced cognitive impairment via modulation of Nrf2/HO-1, endoplasmic reticulum stress, and NLRP3 inflammasome signaling in rats. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 27 May 2026 PMID 42202464
  11. In situ forming hydrogel incorporating celastrol-loaded copper-doped Prussian blue nanoparticles for oxidative stress amplified multimodal breast cancer therapy. International journal of pharmaceutics · 24 May 2026 PMID 42177922
  12. Advanced glycation end-products exacerbate myocardial ischemia/reperfusion injury by promoting mitochondrial oxidative damage and PANoptosis in diabetes mellitus. Redox biology · 23 May 2026 PMID 42176503
  13. Paris polyphylla saponin Ⅱ induces autophagy-associated ferroptosis by regulating the BECLIN1/SLC7A11 axis in cervical cancer. European journal of pharmacology · 20 May 2026 PMID 42162690